Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Poonawalla"


10 mentions found


A nurse fills a syringe with malaria vaccine before administering it to an infant at the Lumumba Sub-County hospital in Kisumu, Kenya, July 1, 2022. REUTERS/Baz Ratner/File photo Acquire Licensing RightsGENEVA, Oct 2 (Reuters) - The World Health Organization (WHO) recommended on Monday the use of a second malaria vaccine to curb the life-threatening disease spread to humans by some mosquitoes. recommended the broad use of the world's first malaria vaccine called RTS,S," WHO chief Tedros Adhanom Ghebreyesus told a briefing in Geneva. "Today, it gives me great pleasure to announce that WHO is recommending a second vaccine called R21/Matrix-M to prevent malaria in children at risk of the disease." "GSK has always recognised the need for a second malaria vaccine, but it is increasingly evident that RTS,S, the first ever malaria vaccine and the first ever vaccine against a human parasite, set a strong benchmark," GSK said in a statement.
Persons: Baz Ratner, Tedros Adhanom Ghebreyesus, Tedros, Poonawalla, Takeda, Hanna Nohynek, Gabrielle Tétrault, Farber, Leroy Leo, Gareth Jones, Mark Potter Organizations: Lumumba, REUTERS, Rights, World Health Organization, WHO, Britain's University of Oxford, UNICEF, Serum Institute of India, Reuters, GSK plc, United Nations, GSK, Takeda Pharmaceuticals, Thomson Locations: Kisumu, Kenya, Geneva, Ghana, Malawi, Bengaluru
How to Wear a Sari? A New Exhibition Counts the Ways.
  + stars: | 2023-05-19 | by ( Phyllida Jay | ) www.nytimes.com   time to read: +1 min
The sari, in essence, is a six- to nine-yard cloth draped freely around the body. In April, Zendaya wore a sparkling deep-blue sari by Rahul Mishra on a red carpet in Mumbai, India. At the 2022 Cannes Film Festival, the Indian actress Deepika Padukone wore a shimmering gold-and-black sari by Sabyasachi Mukherjee that Vogue France called “the star piece” of the festival. Ms. Poonawalla’s Met Gala sari is among the pieces featured in a new exhibition, “The Offbeat Sari,” opening on Friday at the Design Museum in London. The show, which runs through September, explores how the sari is being newly defined, said Priya Khanchandani, the head of curatorial at the museum.
LONDON, April 21 (Reuters) - African countries are lining up to approve a new vaccine for malaria, with 20 million doses available for them to buy this year, the shot’s manufacturer told Reuters. African countries that do not have extensive resources for drug regulation have previously relied on the U.N. agency to initially review new medicines. "We expect many more countries to come through," Mary Hamel, the WHO's malaria vaccine implementation head, told the expert meeting on Tuesday. “We are committed to making the R21 vaccine available to people who need it most,” Poonawalla said. FUNDING DOUBTSThe moves are a further sign that African countries want to exert their own pharmaceutical oversight after COVID-19 exposed inequity in vaccine supply.
China needs to move past political considerations and look at importing Covid-19 jabs to end the pandemic globally, according to the chief executive of the world's latest vaccine manufacturer. The main Covid vaccines approved for use in China are from Sinovac and Sinopharm. These jabs are less effective against the Omicron variant than are other mRNA vaccines, such as Pfizer and BioNTech's, several studies have found. Poonawalla said China's pandemic reaction of 2020 — which included building hospitals and infrastructure and taking precautions — showed that Beijing could respond rapidly. He stressed China's decision not to import vaccines from the U.S., India and elsewhere, which have been "very effective."
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailChina needs to set aside political issues on vaccine imports: Serum Institute of India CEOAdar Poonawalla, chief executive the Serum Institute of India — the world's largest vaccine manufacturer — told CNBC that China needed to open itself up to health care and vaccines from the U.S., India and elsewhere in order to end the pandemic globally.
Adar Poonawalla became the CEO of the world's largest vaccine manufacturer, Serum Institute of India, when he was 30 years old. | Bloomberg | Getty ImagesAdar Poonawalla became the CEO of the world's largest vaccine manufacturer, Serum Institute of India, when he was 30 years old. Today, it is the world's largest vaccine manufacturer — by number of doses produced and sold globally. In 1966, at the age of 25, the elder Poonawalla embarked on a journey to set up the Serum Institute of India. Vaccine production at the Serum Institute of India pharmaceutical plant in Pune, Maharashtra, India.
From its humble beginnings as a horse breeding farm in India to becoming the world's largest vaccine manufacturer, Serum Institute of India has undergone rapid growth throughout the decades to reach its exceptional status. The company faced various challenges from getting permits and licenses to not being able to meet the global demand. But today, it is estimated that more than half the children in the world have been administered with their vaccine. After Adar Poonawalla became the CEO in 2011, he noticed the company did not have enough capacity to meet the growing global demand, leading him to invest more in capacity. As the world learns to live with Covid, Serum Institute also has plans to expand its vaccination portfolio and into the Western markets.
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailSerum Institute of India discusses vaccine distribution in the U.S. and EuropeAdar Poonawalla of the Serum Institute of India says the United States has shown "quite a bit of interest" in its vaccine.
The AstraZeneca vaccine received approval from UK regulators in December 2020, and Poonawalla became a household name in India. India's Covid-19 tsunamiBut Poonawalla's plans soon went awry when a second wave of Covid-19 hit India in the spring. But by January 2021, the company had a stockpile of just 70 million doses . SII also says that it has increased its production to 220 million doses a month as of October. SII is also expanding its partnerships, having signed a deal with American biotech firm Novavax to manufacture its Covid-19 vaccine, which is awaiting regulatory approvals.
Companiile indiene urmează să producă opt vaccinuri mai accesibile, concepute pentru a combate COVID-19, inclusiv Covishield-ul AstraZeneca, numit „vaccinul pentru lumea de aici” de către dezvoltatorii săi, relatează Reuters, citat de libertatea.ro. „Există multe vaccinuri care se produc în țări din întreaga lume, dar există o singură națiune care are capacitatea de a produce cantități suficiente pentru a satisface cerințele cetățenilor din fiecare țară, și asta este India”, a declarat ambasadorul Australiei în India, Barry O’Farrell, după ce a vizitat fabricile de vaccinuri din India împreună cu mulți alți diplomați. Între timp, ambalatorul farmaceutic Schott Kaisha intensifică producția de flacoane de vaccin, iar DHL al Deutsche Post află cum să distribuie cel mai bine dozele în țară și în întreaga lume. Aici, mașinile automate umplu și sigilează mii de flacoane cu doze de la AstraZeneca în fiecare oră înainte de a fi mutate într-o cameră frigorifică vastă, cu tavan înalt. Cu aproape 10 milioane de infecții, cel de-al doilea stat afectat de COVID-19 din lume după Statele Unite, guvernul Indiei este probabil să comande o mare parte din vaccinuri pentru 1,3 miliarde de oameni.
Persons: Barry O’Farrell, . SII, Schott Organizations: libertatea.ro, Pfizer Inc, Serum, DHL, Deutsche Locations: India, Moderna, Australiei, Statele Unite, Indiei
Total: 10